Moxifloxacin-matching Placebo
Sponsors
Actelion, Janssen Research & Development, LLC, Alexion Pharmaceuticals, Inc., Epygenix
Conditions
CardiodynamicsHealthyHealthy ParticipantsPharmacokineticsSafetyTolerability
Phase 1
Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects
CompletedNCT02206204
Start: 2012-06-30End: 2012-11-30Updated: 2014-08-01
A Study to Evaluate the Effects of Ibrutinib on Cardiac Repolarization in Healthy Participants
CompletedNCT02271438
Start: 2014-10-31End: 2015-05-31Updated: 2016-06-06
A Study to Investigate the Effect of JNJ-64565111 on Cardiac Repolarization (Corrected QT Interval) Compared With Placebo in Healthy Adults: a Thorough ECG Study Employing Placebo, JNJ-64565111, and a Positive Control (Moxifloxacin)
CompletedNCT03606057
Start: 2018-07-13End: 2019-02-28Updated: 2020-03-03
A Study of the Cardiac Effects of ALXN2050 in Healthy Adults
CompletedNCT04660890
Start: 2020-12-12End: 2021-03-16Updated: 2021-12-29
A Study of the Cardiac Effects of Danicopan in Healthy Adults
CompletedNCT05016206
Start: 2018-07-26End: 2018-10-12Updated: 2021-08-23
A Single and Multiple Ascending Dose Study of EPX-100 in Healthy Adult Participants
RecruitingNCT07879170
Start: 2026-08-05End: 2026-12-30Target: 88Updated: 2026-10-16